Use of botulinum toxin A in the treatment of bruxism symptoms

Vol. 5 – Number 17 – 2023 Case report Page 10-19 Use of botulinum toxin A in the treatment of bruxism symptoms Carolina Gonçalves1 Sidmarcio Ziroldo2 Ana Paula de Feiras Farias Silva3 Andrea Maluf Dabul Biscaia4 Fabiano Augusto Sfier de Mello5 Joyce Nielsen Araujo6 Thiago Yuiti Castilho Massuda7 ABSTRACT Considered by a disorder of the mandibular movement caused by grinding and exercising the teeth, bruxism has mandibular effect in a large part of the population. Its etiology is multifactorial, and its act is considered a risk factor in several areas of dentistry, affecting the oral health and quality of patients life. An alternative to assist in the treatment of bruxism is the use of botulinum toxin type A, which is currently being used. Produced by an anaerobic gram-positive bacterium called Clostridium Botulinum. Presenting myorelaxant effects at the application site of use, it has shown improvements in muscle use and in pain this pathology causes, as in the clinical case performed. Descriptors: Bruxism, Botulinum Toxin A. 1 Postgraduate student in Orofacial Harmonization – UNIFAZ 2 Teacher. Holder – UNIFAZ, Master in Orthodontics, Specialist in CTBMF, Implantology, Orthodontics and Orofacial Harmonization. 3 Full Professor – UNIFAZ, Master and Specialist in Orofacial Harmonization. 4 Full Professor – UNIFAZ, Master and PhD in Dentistry and Specialist in Orofacial Harmonization. 5 Full Professor – UNIFAZ, Master, Doctor, Specialist in Orofacial Harmonization. 6 Full Professor – UNIFAZ, Hospital Management Specialist and MBA. 7 Full Professor – UNIFAZ, Biomedical and master. DOI: 10.24077/2023;5173187986